• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS Back to Search Results
Model Number DFT015
Medical Device Problem Codes Defective Component (2292); Malposition of Device (2616)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 08/06/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A sample device was not returned for analysis.Complaint history and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A non healthcare professional reported that one of the haptics was broke during an intraocular lens (iol) implantation.The patient was extremely demanding and unfortunately didn't met the expectations.In the post-surgical examinations it was found that the iol was decentralized and that it will be necessary to perform the replacement.Additional information has been requested.
 
Additional Manufacturer Narrative
On initial mdr the event outcome mentioned as reportable malfunction an error.It should have been other medically significant event original mdr.On initial mdr the concomitant products company cartridge and unspecified ovd reported as an error.A qualified cartridge was used.The handpiece and viscoelastic information was not provided.It is unknown if qualified products were used.The product investigation could not identify a root cause for the reported complaint.The product has not returned.It is unknown if a qualified handpiece and viscoelastic were used.The ifu (instruction for use) instructs: company foldable iols are qualified for use with an company qualified delivery system (handpiece and cartridge) and ophthalmic viscosurgical device (ovd) combination.The ifu instructs that an company qualified delivery system and viscoelastic combination should be used.The use of an unqualified combination may cause damage to the lens and potential complications during the implantation process.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
Additional information has been received that during implantation the capsular bag was ruptured.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ VIVITY EXTENDED VISION IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key17690197
Report Number1119421-2023-01564
Device Sequence Number6512810
Product Code POE
UDI-Device Identifier00380652421218
UDI-Public00380652421218
Combination Product (Y/N)N
Initial Reporter CountryBR
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2023
Reporter Type Manufacturer
Report Source Foreign
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 10/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/04/2026
Device Model NumberDFT015
Device Lot Number15240274
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/11/2023
Supplement Date Received by Manufacturer10/04/2023
Initial Report FDA Received Date09/06/2023
Supplement Report FDA Received Date10/30/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/06/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CARTRIDGE D.; MONARCH IOL INJECTOR.; UNSPECIFIED OVD.
Outcome Attributed to Adverse Event Other;
Patient Age76 YR
Patient SexMale
-
-